Closed Loop Medicine Launches First Personalized GLP-1 Dosing Platform in U.S.
Closed Loop Medicine Ltd (CLM), a leader in personalized pharmaceutical dosing, today announced the U.S. launch of WeDosify, which enables clinicians to personalize GLP-1 titration at scale.
Closed Loop Medicine Appoints Luba Greenwood as Chair of the Board of Directors
Closed Loop Medicine Ltd., a leading TechBio company leveraging AI, machine learning, and personalized dosing to enhance drug development, today announced the appointment of Luba Greenwood as Chair of its Board of Directors.
Teva UK and Closed Loop Medicine Announce Strategic Partnership to Advance Development of Personalised Medicines
Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.
Closed Loop Medicine Demonstrates Application of Novel Drug Plus Software Product for Personalized Treatment of Hypertension
Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, today announced the publication of a peer-reviewed study in the Journal of the American Heart Association (JAHA) (1). The study describes results of the PERSONAL-CovidBP clinical trial; demonstrating the capabilities of the Company’s integrated precision care solution, CLM-HT01, to successfully control blood pressure (BP) whilst minimizing side effects and supporting medication adherence in participants with primary hypertension. The findings will be applied to drive further development of CLM-HT01 and the Company’s extended pipeline of combination products in other therapeutic areas, aiming to deliver precision dosing at population scale.
Closed Loop Medicine Appoints Konstantinos Vlassis as Chief Technology Officer
Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that enable personalized dose optimization, today announced that it has appointed Konstantinos Vlassis as Chief Technology Officer (CTO). Bringing extensive expertise in designing and implementing technology strategies to support product delivery, Konstantinos will oversee the management of the Company’s technology platforms and will have responsibility for engineering, information security and technology infrastructure.
Closed Loop Medicine Appoints Kate Woolland as Chief Operating Officer
Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that enable personalized dose optimization, today announced that it has appointed Kate Woolland as Chief Operating Officer. Kate joins CEO, Dr. Hakim Yadi PhD OBE, on the executive team to guide organizational and operational delivery of the Company’s lead programs, products and commercial partnerships.
Closed Loop Medicine Appoints David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer
Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that enable personalised dose optimisation, today announced it has appointed David Van Sickle PhD as Non-Executive Director and Simon Ramsden as Chief Financial Officer. The appointments will support Closed Loop Medicine in the next stage of its growth as the Company expands its development programmes into the US. Currently, it has two clinical-stage products, aiding in the management of insomnia and hypertension, and a pipeline of future combination products that enable dose optimisation to improve patient outcomes.
Closed Loop Medicine Announces Completion of Precision Medicine Clinical Trial for Patients with High Blood Pressure
Closed Loop Medicine Ltd, a leader in the development of single prescription drug plus digital therapy (DTx) combination products to enable precision dosing and care, announced today that the last patient has completed participation in a clinical trial investigating the Company’s integrated precision care product solution for patients with hypertension.
